Market Overview

Earlier Ladenburg Thalmann Initiated Coverage on Cell Therapeutics, Inc. at Buy, Announces $6.00 PT

Share:

Latest Ratings for CTIC

DateFirmActionFromTo
Feb 2016PiperJaffrayDowngradesOverweightNeutral
Feb 2016WallachbethDowngradesHoldSell
Nov 2015WallachbethDowngradesBuyHold

View More Analyst Ratings for CTIC
View the Latest Analyst Ratings

Posted-In: News Analyst Ratings

 

Related Articles (CTIC)